Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:2919-2928
Published online before print June 12, 2006, doi: 10.1161/CIRCULATIONAHA.106.612960
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
113/25/2919    most recent
CIRCULATIONAHA.106.612960v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindsey, M. L.
Right arrow Articles by Spinale, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindsey, M. L.
Right arrow Articles by Spinale, F. G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Other myocardial biology
Right arrow Animal models of human disease
Right arrow Genetically altered mice
Right arrow Heart failure - basic studies
Right arrow Ischemic biology - basic studies

(Circulation. 2006;113:2919-2928.)
© 2006 American Heart Association, Inc.


Heart Failure

Matrix Metalloproteinase-7 Affects Connexin-43 Levels, Electrical Conduction, and Survival After Myocardial Infarction

Merry L. Lindsey, PhD; G. Patricia Escobar, DVM; Rupak Mukherjee, PhD; Danielle K. Goshorn, BS; Nina J. Sheats, BS; James A. Bruce, BS; I. Matthew Mains, BS; Jennifer K. Hendrick, BS; Kenneth W. Hewett, PhD; Robert G. Gourdie, PhD; Lynn M. Matrisian, PhD; Francis G. Spinale, MD, PhD

From the Cardiology Division, Department of Medicine, University of Texas Health Science Center, San Antonio (M.L.L., G.P.E.); Division of Cardiothoracic Surgery Research (R.M., D.K.G., N.J.S., J.A.B., I.M.M., J.K.H., F.G.S.) and Department of Cell Biology and Anatomy (K.W.H., R.G.G.), Medical University of South Carolina, Charleston; Department of Cancer Biology, Vanderbilt University, Nashville, Tenn (L.M.M.); and Ralph H. Johnson Veterans Administration Medical Center, Charleston, SC (F.G.S.).

Correspondence to Merry L. Lindsey, PhD, Cardiology Division, Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, Mail Code 7872, San Antonio, TX 78229-3900. E-mail lindseym{at}uthscsa.edu

Received January 9, 2006; revision received April 17, 2006; accepted April 24, 2006.

Background— Matrix metalloproteinases (MMPs) contribute to left ventricular remodeling after myocardial infarction (MI). Specific causative roles of particular MMPs, however, remain unclear. MMP-7 is abundant in cardiomyocytes and macrophages, but MMP-7 function after MI has not been defined.

Methods and Results— Wild-type (WT; n=55) and MMP-7–null (MMP-7–/–; n=32) mice underwent permanent coronary artery ligation for 7 days. MI sizes were similar, but survival was greatly improved in MMP-7–/– mice. The survival difference could not be attributed to differences in left ventricular dilation because end-diastolic volumes increased similarly. ECG analysis revealed a prolonged PR interval in WT but not in MMP-7–/– post-MI mice. Post-MI conduction velocity, determined by optically mapping electrical wavefront propagation, decreased to 78±6% of control for WT and was normalized in MMP-7–/– mice. In WT mice, slower conduction velocity correlated with a 53% reduction in the gap junction protein connexin-43. Direct binding of MMP-7 to connexin-43, determined by surface plasmon resonance technology, occurred in a dose-dependent manner. Connexin-43 processing by MMP-7 was confirmed by in silico and in vitro substrate analyses and MMP-7 infusion induced arrhythmias in vivo.

Conclusions— MMP-7 deletion results in improved survival and myocardial conduction patterns after MI. This is the first report to implicate MMP-7 in post-MI remodeling and to demonstrate that connexin-43 is a novel MMP-7 substrate.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. K. Mani, S. Balasubramanian, J. A. Zavadzkas, L. B. Jeffords, W. T. Rivers, M. R. Zile, R. Mukherjee, F. G. Spinale, and D. Kuppuswamy
Calpain inhibition preserves myocardial structure and function following myocardial infarction
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1744 - H1751.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
X. Wang, F. L. Chow, T. Oka, L. Hao, A. Lopez-Campistrous, S. Kelly, S. Cooper, J. Odenbach, B. A. Finegan, R. Schulz, et al.
Matrix Metalloproteinase-7 and ADAM-12 (a Disintegrin and Metalloproteinase-12) Define a Signaling Axis in Agonist-Induced Hypertension and Cardiac Hypertrophy
Circulation, May 12, 2009; 119(18): 2480 - 2489.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Klocke, W. Tian, M. T. Kuhlmann, and S. Nikol
Surgical animal models of heart failure related to coronary heart disease
Cardiovasc Res, April 1, 2007; 74(1): 29 - 38.
[Abstract] [Full Text] [PDF]